K-STREET TRACKER
FOLLOW THE MONEY INTO THE SWAMP
Every federal lobbying filing tagged with a public-company ticker — who is spending, which firms they hire, and which members trade right around the filing.
Filings tracked
19,882
thru 2026-05-08
Total reported $
$2.7B
disclosed lobbying
Distinct clients
2,220
paying companies
Tickers targeted
1,207
public companies
💸 Top Spending Clients
| # | Client | Filings | Total $ |
|---|---|---|---|
| 1 |  PFIZER INC.PFE | 47 | $46.8M |
| 2 |  GENERAL MOTORS COMPANYGM | 61 | $46.8M |
| 3 |  META PLATFORMS INC. AND VARIOUS SUBSIDIARIESMETA | 12 | $44.9M |
| 4 | VISA INC.V | 45 | $37.7M |
| 5 |  AMAZON.COM SERVICES LLCAMZN | 36 | $32.8M |
| 6 |  LOCKHEED MARTIN CORPORATIONLMT | 73 | $29.0M |
| 7 |  FEDEX CORPORATIONFDX | 69 | $27.8M |
| 8 |  ELI LILLY AND COMPANYLLY | 56 | $27.1M |
| 9 |  ALTRIA CLIENT SERVICES LLCMO | 142 | $25.2M |
| 10 |  AMGEN INCAMGN | 19 | $24.9M |
| 11 |  COMCAST CORPORATIONCMCSV | 179 | $24.7M |
| 12 |  MERCK & CO INCMRK | 14 | $24.0M |
| 13 |  SOUTHERN COMPANYSO | 53 | $23.9M |
| 14 |  GOOGLE CLIENT SERVICES LLCGOOGL | 79 | $22.6M |
| 15 |  APPLE INCAAPL | 9 | $22.1M |
| 16 |  T-MOBILE USA INC.TMUS | 121 | $21.0M |
| 17 |  UNITEDHEALTH GROUP INCUNH | 19 | $20.4M |
| 18 |  VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIESVZ | 40 | $20.1M |
| 19 |  OCCIDENTAL PETROLEUM CORPORATIONOXY | 30 | $19.7M |
| 20 |  MICROSOFT CORPORATIONMSFT | 103 | $18.8M |
| 21 |  QUALCOMM INCORPORATEDQCOM | 40 | $17.2M |
| 22 |  GENERAL DYNAMICS CORPGD | 11 | $17.0M |
| 23 |  BOEING COMPANYBA | 23 | $16.9M |
| 24 | THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)CI | 13 | $16.9M |
| 25 |  ORACLE CORPORATIONORCL | 58 | $16.7M |
🎯 Top Lobbied Tickers
| # | Ticker | Filings | Total $ |
|---|---|---|---|
| 1 | META Meta Platforms Inc. | 129 | $50.2M |
| 2 | PFE Pfizer Inc. | 87 | $48.6M |
| 3 | GM General Motors Company | 103 | $48.4M |
| 4 | V Visa Inc. | 46 | $37.7M |
| 5 | AMZN Amazon.com Inc. | 80 | $35.3M |
| 6 | LMT Lockheed Martin Corporation | 88 | $29.4M |
| 7 | FDX FedEx Corporation | 82 | $28.3M |
| 8 | LLY Eli Lilly and Company | 83 | $28.1M |
| 9 | AMGN Amgen Inc. | 95 | $28.0M |
| 10 | MRK Merck & Co. Inc. | 92 | $27.5M |
| 11 | AAPL Apple Inc. | 64 | $26.8M |
| 12 | GOOGL Alphabet Inc. Class A | 123 | $26.6M |
| 13 | MO | 164 | $26.2M |
| 14 | SO Southern Company | 108 | $26.1M |
| 15 | UNH UnitedHealth Group Inc. | 67 | $23.9M |
| 16 | VZ Verizon Communications Inc. | 116 | $23.8M |
| 17 | TMUS | 159 | $22.7M |
| 18 |  CHTR | 137 | $22.6M |
| 19 | GD General Dynamics Corporation | 127 | $22.5M |
| 20 |  TAT&T Inc. | 134 | $21.6M |
| 21 | ORCL Oracle Corporation | 132 | $20.6M |
| 22 | CMCSA Comcast Corporation | 141 | $20.4M |
| 23 | CI The Cigna Group | 64 | $19.9M |
| 24 | OXY Occidental Petroleum Corporation | 36 | $19.9M |
| 25 | MSFT Microsoft Corporation | 122 | $19.2M |
🆕 Filtered Filings · TMO
clear filters| Date | Ticker | Client | Registrant | Amount | Issue |
|---|---|---|---|---|---|
| 2026-04-20 | TMO | THERMO FISHER SCIENTIFIC INC | MONUMENT ADVOCACY | $60K | General Thermo Fisher Scientific education, National Institutes of Health funding, future pandemic preparedness and response. General Thermo Fisher Scientific education, National Institutes of Health funding, future pandemic preparedness and response. |
| 2026-04-20 | TMO | THERMO FISHER SCIENTIFIC INC | ERNST & YOUNG LLP (WASHINGTON COUNCIL ERNST & YOUNG) | $0 | |
| 2026-04-17 | TMO | THERMO FISHER SCIENTIFIC INC | GORDON THOMAS HONEYWELL GOVERNMENTAL AFFAIRS | $30K | Budget Law Enforcement/Criminal Justice - DNA |
| 2026-04-16 | TMO | THERMO FISHER SCIENTIFIC INC | THERMO FISHER SCIENTIFIC INC. | $710K | General discussions related to clinical trials infrastructure and government labs, and related matters. General discussions regarding diagnostic reimbursement policies. H.R. 5269/S. 2761: Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act of 2025 - all provisions of the bill. H.R. 5343/S. 1717: Ensuring Patient Access to Critical Breakthrough Products Act - all provisions of the bill. H.R. 5304/S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 - provisions regarding FY26 NIH Funding. General discussions regarding government contract thresholds. Preparedness products and services. General discussions around government contracting opportunities. POWER Act; all provisions of the bill. General discussions regarding trade and tariffs, including with respect to markets including China. United States-Mexico-Canada Agreement. General discussions regarding the expiration of key p |
| 2026-04-06 | TMO | THERMO FISHER SCIENTIFIC INC | BLUEBIRD STRATEGIES | $21K | Engage Senate and House on proposed legislation to promote the appropriate use of FDA cleared preeclampsia biomarker testing as part of the Medicaid program |
| 2026-01-21 | TMO | THERMO FISHER SCIENTIFIC INC | BLUEBIRD STRATEGIES | $12K | Engage Senate and House on proposed legislation to promote the appropriate use of FDA cleared preeclampsia biomarker testing as part of the Medicaid program |
| 2026-01-20 | TMO | THERMO FISHER SCIENTIFIC INC | MONUMENT ADVOCACY | $70K | General Thermo Fisher Scientific education, National Institutes of Health funding, future pandemic preparedness and response. General Thermo Fisher Scientific education, National Institutes of Health funding, future pandemic preparedness and response. Issues related to the deployment of Rapid DNA technologies. |
| 2026-01-20 | TMO | THERMO FISHER SCIENTIFIC | MANATT, PHELPS, AND PHILLIPS | $0 | |
| 2026-01-19 | TMO | THERMO FISHER SCIENTIFIC INC | THERMO FISHER SCIENTIFIC INC. | $470K | General discussions related to clinical trials infrastructure and government labs, and related matters. General discussions regarding diagnostic reimbursement policies. H.R. 5269/S. 2761: Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act of 2025 - all provisions of the bill. H.R. 3543: Ensuring Patient Access to Critical Breakthrough Products Act - all provisions of the bill. H.R. 5304/S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 - provisions regarding FY26 NIH Funding General discussions regarding government contract thresholds Preparedness products and services P.L. 91-513: Issues related to the Controlled Substances Act General discussions around government contracting opportunities POWER Act; all provisions of the bill. General discussions regarding trade and tariffs, including with respect to markets including China. United States-Mexico-Canada Agreement. Trade |
| 2026-01-19 | TMO | THERMO FISHER SCIENTIFIC INC | ERNST & YOUNG LLP (WASHINGTON COUNCIL ERNST & YOUNG) | $0 | |
| 2026-01-12 | TMO | THERMO FISHER SCIENTIFIC INC | GORDON THOMAS HONEYWELL GOVERNMENTAL AFFAIRS | $30K | Budget Law Enforcement/Criminal Justice - DNA |
| 2025-11-09 | TMO | THERMO FISHER SCIENTIFIC INC | BLUEBIRD STRATEGIES | $12K | Engage Senate and House on proposed legislation to promote the appropriate use of FDA cleared preeclampsia biomarker testing as part of the Medicaid program |
| 2025-10-20 | TMO | THERMO FISHER SCIENTIFIC INC | THERMO FISHER SCIENTIFIC INC. | $430K | General discussions related to clinical trials infrastructure and government labs. General discussions regarding diagnostic reimbursement policies. H.R. 5269/S. 2761: Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act of 2025 - all provisions of the bill. H.R. 3543: Ensuring Patient Access to Critical Breakthrough Products Act - all provisions of the bill. Executive Order 14336: Ensuring American Pharmaceutical Supply Chain Resilience By Filling the Strategic Active Pharmaceutical Ingredients Reserve - all provisions of the order. H.R. 5304/S. 2587: FY26 NIH Funding General discussions regarding government efficiency opportunities and government contract thresholds Preparedness products and services P.L. 91-513: Issues related to the Controlled Substances Act General discussions around government contracting opportunities POWER Act; all provisions of the bill. General discussions regarding trade and tariffs, including with respect to market |
| 2025-10-20 | TMO | THERMO FISHER SCIENTIFIC INC | MONUMENT ADVOCACY | $80K | General Thermo Fisher Scientific education, National Institutes of Health funding, future pandemic preparedness and response. General Thermo Fisher Scientific education, National Institutes of Health funding, future pandemic preparedness and response. Issues related to the deployment of Rapid DNA technologies. |
| 2025-10-20 | TMO | THERMO FISHER SCIENTIFIC INC | GORDON THOMAS HONEYWELL GOVERNMENTAL AFFAIRS | $30K | Budget Law Enforcement/Criminal Justice - DNA |
| 2025-10-19 | TMO | THERMO FISHER SCIENTIFIC INC | ERNST & YOUNG LLP (WASHINGTON COUNCIL ERNST & YOUNG) | $0 | |
| 2025-10-16 | TMO | THERMO FISHER SCIENTIFIC | MANATT, PHELPS, AND PHILLIPS | $15K | Regulation of in vitro diagnostics and lab-developed tests |
| 2025-08-01 | TMO | THERMO FISHER SCIENTIFIC INC | BLUEBIRD STRATEGIES | $12K | Engage Senate and House on proposed legislation to promote the appropriate use of FDA cleared preeclampsia biomarker testing as part of the Medicaid program |
| 2025-07-21 | TMO | THERMO FISHER SCIENTIFIC INC | MONUMENT ADVOCACY | $90K | General Thermo Fisher Scientific education, National Institutes of Health funding, future pandemic preparedness and response. General Thermo Fisher Scientific education, National Institutes of Health funding, future pandemic preparedness and response. |
| 2025-07-21 | TMO | THERMO FISHER SCIENTIFIC INC | ERNST & YOUNG LLP (WASHINGTON COUNCIL ERNST & YOUNG) | $60K | - Manufacturing tax credit - R&D tax credit - International tax issues: The deduction for Foreign-Derived Intangible Income (FDII), the minimum tax on Global Intangible Low-Taxed Income (GILTI), and OECD Pillar 2 issues - Title VII of H.R. 1, the One Big, Beautiful Bill Act (budget reconciliation bill, P.L. 119-21) |
| 2025-07-18 | TMO | THERMO FISHER SCIENTIFIC INC | THERMO FISHER SCIENTIFIC INC. | $400K | General discussions regarding trade and tariffs, including with respect to markets including China. United States-Mexico-Canada Agreement. General discussions regarding the expiration of key provisions of the 2017 Tax Cuts and Jobs Act, and other tax-related priorities. Verifying Accurate Leading-edge IVCT Development (VALID) Act; all provisions of the bill. Saving Access for Laboratory Services (SALSA) Act; all provisions of the bill. Clinical trials infrastructure. General discussions regarding diagnostic reimbursement policies. FDA Final Rule on Laboratory Developed Tests (LDTs). FY26 NIH Funding. General discussions regarding government efficiency opportunities. P.L. 117-58: Infrastructure Investment and Jobs Act; provisions related to environmental monitoring. P.L. 117-169: Inflation Reduction Act; provisions related to environmental monitoring. P.L. 116-260: American Innovation and Manufacturing Act; provisions related to regulated substances. P.L. 114-182: Frank R. Laute |
| 2025-07-18 | TMO | THERMO FISHER SCIENTIFIC INC | GORDON THOMAS HONEYWELL GOVERNMENTAL AFFAIRS | $30K | Budget Law Enforcement/Criminal Justice - DNA |
| 2025-07-17 | TMO | THERMO FISHER SCIENTIFIC | MANATT, PHELPS, AND PHILLIPS | $15K | Regulation of in vitro diagnostics and lab-developed tests |
| 2025-05-06 | TMO | THERMO FISHER SCIENTIFIC | MANATT, PHELPS, AND PHILLIPS | $15K | Regulation of in vitro diagnostics and lab-developed tests |
| 2025-04-23 | TMO | THERMO FISHER SCIENTIFIC INC | BLUEBIRD STRATEGIES | $12K | Engage Senate and House on proposed legislation to promote the appropriate use of FDA cleared preeclampsia biomarker testing as part of the Medicaid program |
| 2025-04-21 | TMO | THERMO FISHER SCIENTIFIC INC | MONUMENT ADVOCACY | $90K | General Thermo Fisher Scientific education, National Institutes of Health funding, future pandemic preparedness and response. General Thermo Fisher Scientific education, National Institutes of Health funding, future pandemic preparedness and response. |
| 2025-04-21 | TMO | THERMO FISHER SCIENTIFIC INC | ERNST & YOUNG LLP (WASHINGTON COUNCIL ERNST & YOUNG) | $60K | - R&D tax credit - Issues related to the Tax Cuts & Jobs Act (PL 115-97), including the deduction for Foreign-Derived Intangible Income (FDII) and the minimum tax on Global Intangible Low-Taxed Income (GILTI) |
| 2025-04-18 | TMO | THERMO FISHER SCIENTIFIC INC | GORDON THOMAS HONEYWELL GOVERNMENTAL AFFAIRS | $30K | Budget Law Enforcement/Criminal Justice - DNA |
| 2025-04-16 | TMO | THERMO FISHER SCIENTIFIC INC | THERMO FISHER SCIENTIFIC INC. | $1.4M | Verifying Accurate Leading-edge IVCT Development (VALID) Act; all provisions of the bill. Saving Access for Laboratory Services (SALSA) Act; all provisions of the bill. Clinical trials infrastructure. General discussions regarding diagnostic reimbursement policies. FDA Final Rule on Laboratory Developed Tests (LDTs). FY25 draft LHHS bill: provisions related to NIH, ARPA-H. FY26 NIH Funding. P.L. 117-58: Infrastructure Investment and Jobs Act; provisions related to environmental monitoring. P.L. 117-169: Inflation Reduction Act; provisions related to environmental monitoring. P.L. 116-260: American Innovation and Manufacturing Act; provisions related to regulated substances. P.L. 114-182: Frank R. Lautenberg Chemical Safety for the 21st Century Act; provisions related to the use of certain chemicals. P.L. 91-604: National Ambient Air Quality Standards; provisions relating to ethylene oxide emissions. P.L 117-167: CHIPS and Science Act of 2022; provisions related to semiconductor c |
| 2025-03-18 | TMO | THERMO FISHER SCIENTIFIC | MANATT, PHELPS, AND PHILLIPS | $15K | Regulation of in vitro diagnostics and lab-developed tests |
| 2025-03-12 | TMO | THERMO FISHER SCIENTIFIC | MANATT, PHELPS, AND PHILLIPS | $0 | Regulation of in vitro diagnostics and lab-developed tests |
| 2025-01-21 | TMO | THERMO FISHER SCIENTIFIC INC | MONUMENT ADVOCACY | $60K | General Thermo Fisher Scientific education, National Institutes of Health funding, future pandemic preparedness and response. General Thermo Fisher Scientific education, National Institutes of Health funding, future pandemic preparedness and response. |
| 2025-01-21 | TMO | THERMO FISHER SCIENTIFIC | MANATT, PHELPS, AND PHILLIPS | $15K | Regulation of in vitro diagnostics and lab-developed tests |
| 2025-01-20 | TMO | THERMO FISHER SCIENTIFIC INC | THERMO FISHER SCIENTIFIC INC. | $390K | H.R. 2369: Verifying Accurate Leading-edge IVCT Development (VALID) Act; all provisions of the bill. H.R. 2377/S. 1000: Saving Access for Laboratory Services (SALSA) Act; all provisions of the bill. Draft Pandemic and All-Hazards Preparedness Reauthorization. Clinical trials infrastructure. General discussions regarding diagnostic reimbursement policies. FDA Final Rule on Laboratory Developed Tests (LDTs). H.R. 7085 BIOSECURE Act; all provisions of the bill. FY24 draft LHHS bill: provisions related to NIH, ARPA-H. FY25 draft LHHS bill: provisions related to NIH, ARPA-H. General discussions regarding the expiration of key provisions of the 2017 Tax Cuts and Jobs Act, including those related to Foreign-Derived Intangible Income. H.R. 3938: Build It in America Act; provisions related to expense of research and development costs. P.L. 117-58: Infrastructure Investment and Jobs Act; provisions related to environmental monitoring. P.L. 117-169: Inflation Reduction Act; provisions relat |
| 2025-01-20 | TMO | THERMO FISHER SCIENTIFIC INC | ERNST & YOUNG LLP (WASHINGTON COUNCIL ERNST & YOUNG) | $60K | - R&D tax credit - Issues related to the Tax Cuts & Jobs Act (PL 115-97), including the deduction for Foreign-Derived Intangible Income (FDII) and the minimum tax on Global Intangible Low-Taxed Income (GILTI) |
| 2025-01-20 | TMO | THERMO FISHER SCIENTIFIC INC | BLUEBIRD STRATEGIES | $30K | Pioneering Antimicrobial Subscriptions to End Upsurging Resistance PASTEUR Act and issues related to sepsis treatment and antibiotic stewardship. CMS SEP-1 measure implementation. CDC AMR activities. Issues related to health insurance coverage and regulation of FDA cleared biomarkers to predict preeclampsia. |
| 2025-01-20 | TMO | THERMO FISHER SCIENTIFIC INC | GORDON THOMAS HONEYWELL GOVERNMENTAL AFFAIRS | $30K | HR 5893 / S. 2321 - provisions related to forensic DNA funding HR 1105 / S. 499 -- Debbie Smith DNA Backlog Elimination Reauthorization Act |